Welcome

Thank you for visiting Paducahsun.com, online home of The Paducah Sun.

Calendar
June 2012
S M T W T F S
27 28 29 30 31 01 02

Click here to submit an event.

Panel votes down heart safety claim for drug naproxen

SILVER SPRING, Md. - A majority of federal health specialists said Tuesday that new research is not strong enough to conclude that naproxen, the pain reliever in Aleve and many other medications, is safer on the heart than rival drugs used by millions of Americans to treat arthritis and everyday aches and pains.

The Food and Drug Administration advisory panel voted 16-9 against the conclusion that naproxen has a lower risk of heart attack and stroke than similar anti-inflammatory medications like ibuprofen, sold as Advil and in other generic formulations.

The drugs, known as non-steroidal anti-inflammatory drugs or NSAIDs, include over-the-counter medications like Aleve and Motrin as well as more high-powered prescription drugs like Celebrex, marketed by Pfizer to treat arthritis. Uniform labeling across all the drugs warns that they can increase the risk of heart attack and other life-threatening cardiovascular events. But debate over whether one drug in the class is actually safer than others has waged for more than a decade without a clear answer.

The FDA convened a two-day meeting this week to review the latest evidence, including a massive analysis published last year suggesting naproxen does not increase the risk of heart problems as much as its peers. Despite an apparent "drift" toward fewer heart problems with naproxen, a majority of panelists said the evidence was not conclusive and did not warrant changing the drug's label.

"If I were forced to bet on what the truth is, my bet would be that naproxen is somewhat safer," said panelist Dr. Susan Ellenberg of the University of Pennsylvania. "On the other hand, I'm not sure how that relates to our regulatory standard, as there's still a lot of uncertainty here."

Panelists who voted in favor of naproxen's safety conceded that the evidence is not definitive, but also cited a "duty to inform the public."

"I'm convinced enough to change my own use of NSAIDs to naproxen - and that of my patients - based on what I've heard these last two days," said panelist Dr. Peter Kaboli of the University of Iowa.

The findings favoring naproxen came from Oxford University researchers who combined results from more than 700 NSAID studies and found fewer heart problems with over-the-counter and prescription naproxen. But most panelists said those results were difficult to interpret.

Comments made about this article - 0 Total

Comment on this article

Your comment has been submitted for approval
captcha 2977eb9eba7b45ebab9584cb977d28dc
Top Classifieds
  • HAPPY JACK® MITEX®:with Ear C ... Details
  • 6 AKC registered Rottweiler Puppies, ... Details
  • Patented Happy Jack Flea Beacon:Contr ... Details
  • 13 yr. old Tenn. Walking Horse Geldin ... Details
  • Toro Z-master Mower, 52in cut, 19hors ... Details
  • FAIRHURST BUILDING Professional Offic ... Details
  • Westend duplex for sale by owner, $14 ... Details
  • SEEING is believing! Don't buy p ... Details
  • 6 Acres for sale located Massac Churc ... Details

Most Popular
  1. Advocates fan out across globe to support science on Earth Day
  2. Health quagmire, possible shutdown await Congress
  3. Some 30,000 coming to town for QuiltWeek
  1. Francesca's to open boutique in Paducah
  2. Lexington woman watched race horse Man o' War pose for statue
  3. Trump, Bevin should reveal returns
  1. Advocates fan out across globe to support science on Earth Day
  2. Health quagmire, possible shutdown await Congress
  3. 'Blue Zones' initiative plans moving forward
Discussion

Check out these recently discussed stories and voice your opinion...